Tibor Harkany - Curriculum Vitae#

Education, academic degrees & docentship (“habilitation”):

• 2005 Docent in Neuropharmacology (Dnr. 3664/2005), Karolinska Institutet, Stockholm, Sweden
  
• 1999 PhD in Medical Sciences (summa cum laude). Semmelweis Medical School, Budapest, Hungary (No. 249)
  
• 1995 M.Sc. (No. 291/1995), József Attila University, Szeged, Hungary

Commission of trust:

• 2016 Invited panellist for the H2020 call 'Health, Demographic Change and Wellbeing'
  
• 2012, 2015 Panelist for the Life & Health Sciences 2015 Call of Fundação para a Ciência e a Tecnologia (FCT), Lisboa, Portugal.
  
• 2015 Panelist for the Neuroscience Board, Hungarian National Research Council (OTKA), Budapest, Hungary.
  
• 2014 Mid-term review committee member, Swammerdam Institue for Life Sciences (SILS), University of Amsterdam.
  
• 2014- Peer review evaluator for Horizon2020 (advanced ERC grants and health call).
  
• 2013 Review board member, “EU Joint Programme – Neurodegenerative Disease Research” (JPND).
  
• 2012-2013 Peer review evaluator for FP7 “Ideas” work programme (advanced ERC grants).
  
• 2012-2013 KID funding panel member of the Karolinska Institutet (2 funding cycles/year).
  
• 2012 Reviewer, Karolinska Institutet-NIH Training Program in Neuroscience.
  
• 2009-present Interviewer and evaluator, EMBO long-term and short-term fellowship (>20 grants), on-going.
  
• 2008 Review board member of Era-Net NEURON/neurodegenerative diseases for the European Commission (2008).
  

Recent research grants:

• 2015-2016 Novo Nordisk Foundation (Denmark), principal investigator
  
• 2015-2016 Hjärnfonden (Swedish Brain Research Foundation), principal investigator
  
• 2015 GW Pharmaceuticals, Histon/Cambridge, United Kingdom, principal investigator
  
• 2014-2017 European Union 7th Framework programme, PAINCAGE integrated project, #603191, work package leader
  
• 2014 Petrus & Augusta Hedlunds Foundation (Sweden; competitive renewal), co-principal investigator
  
• 2014 Novo Nordisk Foundation (Denmark; competitive renewal), principal investigator
  
• 2014-2018 Swedish Medical Research Council (Vetenskapsrådet), principal investigator
  

Organization:

2015 Gordon Research Conference “Cannabinoid Functions in the CNS”, chair (with M. Maccarrone), Il Ciocco Resort, Tuscany, Italy

Editorial boards:

• 2006 Editorial board member, Current Signal Transduction Therapy, Bentham Scientific Publisher
  
• 2008 Honorary editorial board member, International Journal of BioSciences and Technology
  
• 2008 Scientific review associate, European Journal of Neuroscience
  
• 2010 Review editor, Frontiers in Systems Biology
  
• 2010 Review editor, Frontiers in Neurodegenerative Diseases
  
• 2012 Editorial board member, Dataset Papers in Neuroscience
  
• 2013 Editorial board member, Journal of Biochemistry & Biophysics
  
• 2015 Field editor (Neuroscience), Amino Acids (Springer)
  
• 2016 Editorial board member, Cannabis and Cannabinoid Research (Mary Ann Liebert Inc.)
  
• 2016 Editorial board member/assoc. editor, Acta Neuropathologica Communications (Springer)
  
• 2011 Guest editor: “Molecular mechanisms of neuronal specification” – European Journal of Neuroscience, Special Issue
  
• 2014 Guest editor: “Neurotrophin-endocannabinoid interactions in pain” – European Journal of Neuroscience, Special Issue